Neurocrine Bioscience buy Morgan Stanley

Summary

This prediction ended on 05.02.26 with a price of €115.65. The price of Neurocrine Bioscience has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.86%. Morgan_Stanley has a follow-up prediction for Neurocrine Bioscience where he still thinks Neurocrine Bioscience is a Buy. Morgan_Stanley has 50% into this prediction

Performance without dividends (%)

Name	1w	1m	1y
Neurocrine Bioscience	-1.296%	-1.296%	5.694%
iShares Core DAX®	-5,87 %	-2,50 %	2,29 %
iShares Nasdaq 100	1,66 %	3,51 %	13,19 %
iShares Nikkei 225®	-6,13 %	2,14 %	27,67 %
iShares S&P 500	0,50 %	2,05 %	9,82 %